Company Announcements

Form 38.5(b) - Willis Towers Watson PLC

Source: RNS
RNS Number : 8994I
Goldman Sachs & Co. LLC
06 April 2020
 

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

1. KEY INFORMATION

 

Name of exempt principal trader

GOLDMAN SACHS & CO. LLC

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note1)

USD 0.000304635 ordinary shares

Date of dealing

03 April 2020

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 2)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

243,118.458

(0.18)

261,294.458

(0.20)

(2) Derivatives (other than options)

118,007

(0.09)

96,567

(0.07)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

361,125.458

(0.28)

357,861.458

(0.27)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 2)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

3.    DEALINGS (Note 3)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 4)

Purchase

798

157.0900 USD

Purchase

1,277

157.0900 USD

Purchase

395

157.0900 USD

Purchase

15

157.0900 USD

Purchase

385

157.0900 USD

Sale

17

157.0700 USD

Sale

100

157.0800 USD

Sale

8,215

157.0900 USD

Sale

299

157.0900 USD

Sale

2,761

157.0900 USD

Sale

125

157.0900 USD

Sale

1,333

157.0900 USD

Sale

840

157.0900 USD

Sale

1,001

157.0900 USD

Sale

17

157.0900 USD

Sale

390

157.0900 USD

Sale

83

157.7600 USD

Sale (Borrow Partial Return)

900

N/A

Purchase (Loan Partial Return)

65

N/A

Purchase (Loan Partial Return)

717

N/A

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 5)

Number of relevant securities  (Note 6)

Price per unit  (Note 4)

 

 

 

 

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 4)

 

 

 

 

 

 

 

 

(ii)            Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 4)

 

 

 

 

(d)            Other dealings (including transactions in respect of new securities)  (Note 3)

 

Nature of transaction  (Note 7)

Details

Price per unit (if applicable)  (Note 4)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9)        YES

 

Date of disclosure

06 April 2020

Contact name

Kashif Rafiq and Papa Lette

Telephone number

+44(20) 7051 0547 / +44(20) 7774 7442

Name of offeree/offeror with which connected

WILLIS TOWERS WATSON PLC

Nature of connection (Note 9)

Advisor to Offeree

 

SUPPLEMENTAL FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

OPEN POSITIONS (Note 1)

 

Product name,e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Swap

Sold

56

0.0000

N/A

29/04/2020

Swap

Sold

185

0.0000

N/A

23/09/2020

Swap

Sold

14,499

0.0000

N/A

14/04/2021

Swap

Sold

18,503

0.0000

N/A

14/04/2021

 

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rules 8 and 38.5 of the Rules. If in doubt, consult the Panel.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEUPUQUCUPUGUQ